Free Trial

Marathon Asset Management Ltd Reduces Holdings in Envista Holdings Corporation (NYSE:NVST)

Envista logo with Medical background

Marathon Asset Management Ltd decreased its holdings in Envista Holdings Corporation (NYSE:NVST - Free Report) by 9.6% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 963,584 shares of the company's stock after selling 102,719 shares during the period. Marathon Asset Management Ltd owned about 0.56% of Envista worth $16,632,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. Brickwood Asset Management LLP raised its holdings in Envista by 0.3% in the 1st quarter. Brickwood Asset Management LLP now owns 2,080,971 shares of the company's stock valued at $35,918,000 after acquiring an additional 5,416 shares during the period. Palouse Capital Management Inc. grew its position in shares of Envista by 14.4% in the first quarter. Palouse Capital Management Inc. now owns 9,444 shares of the company's stock valued at $163,000 after purchasing an additional 1,186 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in shares of Envista by 220.5% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 47,319 shares of the company's stock worth $817,000 after purchasing an additional 32,556 shares during the period. SG Americas Securities LLC lifted its holdings in Envista by 594.3% during the 1st quarter. SG Americas Securities LLC now owns 108,509 shares of the company's stock worth $1,873,000 after purchasing an additional 92,880 shares during the last quarter. Finally, UMB Bank n.a. boosted its stake in Envista by 214.4% in the 1st quarter. UMB Bank n.a. now owns 2,094 shares of the company's stock valued at $36,000 after purchasing an additional 1,428 shares during the period.

Envista Stock Performance

Shares of NYSE NVST traded up $0.46 during trading on Tuesday, reaching $20.00. 2,676,345 shares of the company traded hands, compared to its average volume of 2,659,623. The company has a quick ratio of 1.82, a current ratio of 2.12 and a debt-to-equity ratio of 0.43. The firm has a 50 day simple moving average of $17.89 and a 200-day simple moving average of $18.42. Envista Holdings Corporation has a 52-week low of $14.22 and a 52-week high of $23.00. The stock has a market capitalization of $3.39 billion, a PE ratio of -3.06, a P/E/G ratio of 1.25 and a beta of 0.99.

Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.20 by $0.04. Envista had a positive return on equity of 4.07% and a negative net margin of 44.90%. The business had revenue of $616.90 million during the quarter, compared to the consensus estimate of $608.17 million. During the same period in the previous year, the company posted $0.26 EPS. The business's quarterly revenue was down 1.1% compared to the same quarter last year. Equities research analysts anticipate that Envista Holdings Corporation will post 1 earnings per share for the current year.

Analysts Set New Price Targets

NVST has been the topic of a number of recent research reports. Morgan Stanley set a $16.00 price target on shares of Envista in a research report on Tuesday, April 15th. Robert W. Baird raised shares of Envista from a "neutral" rating to an "outperform" rating and raised their target price for the stock from $21.00 to $23.00 in a report on Tuesday, May 27th. Needham & Company LLC reiterated a "hold" rating on shares of Envista in a research note on Thursday, March 6th. New Street Research set a $19.00 price target on Envista in a research report on Thursday, March 6th. Finally, UBS Group lowered their price objective on Envista from $21.00 to $18.00 and set a "neutral" rating on the stock in a research note on Monday, May 5th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Envista currently has an average rating of "Hold" and a consensus target price of $20.23.

Read Our Latest Stock Report on NVST

About Envista

(Free Report)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

Read More

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Should You Invest $1,000 in Envista Right Now?

Before you consider Envista, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.

While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines